Enbiosis AI-Powered Microbiome Analysis Now Available Through Evexia Diagnostics

Enbiosis AI-Powered Microbiome Analysis Now Available Through Evexia Diagnostics: Empowering Functional and Integrative Medicine Practitioners with Targeted Gut Microbiome Modulation

We are excited to announce that Enbiosis Biotechnology has partnered with Evexia Diagnostics, making our AI-powered microbiome analysis accessible to thousands of Functional Medicine and Integrative Medicine practitioners across the United States. This collaboration marks a significant step forward in empowering healthcare providers to offer their patients personalized solutions for gut health, disease risk management, and holistic well-being.

Evexia Diagnostics, a leader in clinical laboratory services since 2017, offers an extensive range of diagnostics and specialty tests tailored to the needs of Functional and Integrative Medicine practitioners. Known for fast, reliable, and affordable solutions, Evexia’s comprehensive diagnostic testing aligns perfectly with Enbiosis’ mission to deliver cutting-edge AI-powered microbiome analysis, helping clinicians dive deeper into the root cause of health problems and deliver precision medicine to their patients.

Through this collaboration, practitioners can now order Enbiosis’ AI-driven microbiome analysis, empowering them to provide patients with actionable insights based on their gut health. By interpreting complex microbiome data, our platform helps tailor food and supplement recommendations, giving practitioners a powerful tool to support individualized care and enhance patient outcomes.

Ryan Obermeier, Chief Commercial Officer at Evexia Diagnostics, shares his enthusiasm for this collaboration:

“Enbiosis is one of the first companies with which Evexia Diagnostics has partnered that applies artificial intelligence algorithms to its analysis and suggested interventions. It’s an organization that not only focuses on delivering a product but also accompanies it with strong research. As its AI matures within the integrative/functional medicine space, I am excited to see how Enbiosis will evolve beyond what it currently offers. The organization has a very exciting future.”

The addition of Enbiosis’ AI-powered microbiome testing to Evexia’s diagnostics suite enables practitioners to go beyond standard testing. Now, functional and integrative medicine professionals can access powerful insights into the gut microbiome and deliver personalized, evidence-based interventions to their patients.

Key Features of the Collaboration:

• AI-Powered Microbiome Analysis: Leverage artificial intelligence to interpret microbiome data and create tailored, actionable insights for patient care.
• Functional & Integrative Medicine Focus: Serving practitioners who focus on holistic health, nutrition-based care, and personalized interventions.
• Comprehensive Diagnostics: Available through Evexia Diagnostics’ trusted platform, which supports a wide array of specialty tests, at-home diagnostics, and clinical laboratory services.

To view Enbiosis’ page on Evexia’s platform and become a client, please visit:
https://www.evexiadiagnostics.com/diagnostic-testing/laboratory-partners/enbiosis

To watch the Enbiosis webinar by our CTO, Özkan Ufuk Nalbantoğlu, Ph.D., on AI-powered microbiome analysis, visit:
https://www.evexiadiagnostics.com/provider-solutions/evexia-webinar-series/enbiosis-ai-powered-microbiome-analysis/

This partnership is a critical advancement in providing personalized patient care. By integrating Enbiosis’ AI-powered microbiome analysis into their offerings, Evexia continues to support practitioners who are shaping the future of healthcare with a holistic, integrative approach.